Whereas, in mice with adipose-specific mTORC1 inhibition, the function of SREBP1 is abrogated, leading to decreased hepatic steatosis and hypercholesterolemia induced by a high-fat diet [30]. Here, SREBF1 is linked to fatty liver disease.